Issue

Vol. 65 No. 3: Issue 3

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

Relationship between the methylation levels of Twist gene and pathogenesis of endometriosis

https://doi.org/10.14715/cmb/2019.65.3.14
Li Juanqing
Gynecology Department, Women's Hospital School of Medicine Zhejiang University, Xueshi Road 1st, Zhejiang Hangzhou 310006, China
Yu Hailan
Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital School of Medicine Zhejiang University, Qingchun Road 3rd, Zhejiang Hangzhou 310016, China
Fei Xiangwei
Gynecology Department, Women's Hospital School of Medicine Zhejiang University, Xueshi Road 1st, Zhejiang Hangzhou 310006, China
Zhang Tao
Gynecology Department, Women's Hospital School of Medicine Zhejiang University, Xueshi Road 1st, Zhejiang Hangzhou 310006, China
Ma Junyan
Gynecology Department, Women's Hospital School of Medicine Zhejiang University, Xueshi Road 1st, Zhejiang Hangzhou 310006, China
Zhou Jianhong
Gynecology Department, Women's Hospital School of Medicine Zhejiang University, Xueshi Road 1st, Zhejiang Hangzhou 310006, China
Lin Jun
Gynecology Department, Women's Hospital School of Medicine Zhejiang University, Xueshi Road 1st, Zhejiang Hangzhou 310006, China
Yang Jianhua
Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital School of Medicine Zhejiang University, Qingchun Road 3rd, Zhejiang Hangzhou 310016, China

Corresponding Author(s) : Yang Jianhua

zrtazz3@163.com

Cellular and Molecular Biology, Vol. 65 No. 3: Issue 3

Abstract

The purpose of this study was to investigate the difference of Twist gene promoter methylation among ovarian ectopic endometrium, eutopic endometrium and non-endometriosis (EMs) endometrium . 15 patients with reproductive age hospitalized at Department of obstetrics and gynecology affiliated to Medicine School of Zhejiang University from January 2013 to June 2016 were selected. Among them, 5 patients underwent laparoscopic surgery due to ovarian type EMs, and were selected after histologic confirmation. Ectopic endometrium and eutopic endometrium were obtained simultaneously. Normal endometrium was obtained from 5 cases of tubal infertility confirmed by hysteroscopy. Six pairs of primers for CpG island of Twist gene promoter were designed, and the difference of promoter methylation levels was detected by pyrosequencing method for methylation specific PCR (MSP) in three groups of endometrial tissues. The promoter of Twist gene is hypomethylated in some areas of ovarian ectopic endometrium and eutopic endometrium of ovarian endometriosis. It is speculated that the regional hypomethylation of Twist gene promoter in ovarian ectopic endometrium and eutopic endometrium may cause over-expression of Twist protein, which may directly lead to the pathogenesis of endometriosis.

Keywords

Twist Ectopic endometrium Eutopic endometrium Non-endometriosis (EMs) endometrium.
Juanqing, L., Hailan, Y., Xiangwei, F., Tao, Z., Junyan, M., Jianhong, Z., Jun, L., & Jianhua, Y. (2019). Relationship between the methylation levels of Twist gene and pathogenesis of endometriosis. Cellular and Molecular Biology, 65(3), 94–100. https://doi.org/10.14715/cmb/2019.65.3.14
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. He JX, Chang WQ, Feng CY, Cui MH, Xu TM. Endometriosis Malignant Transformation: Epigenetics as a Probable Mechanism in Ovarian Tumorigenesis. Int J Genomics 2018; 2018: 1-13.
  2. Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 2014; 10:261-275.
  3. Borghese B, Zondervan KT, Abrao MS, Chapron C, Vaiman D. Recent insights on the genetics and epigenetics of endometriosis. Clin Genet 2016; 91: 254-264.
  4. Calicchio R, Doridot L, Miralles F, Méhats C, Vaiman D. DNA methylation, an epigenetic mode of gene expression regulation in reproductive science. Curr Pharm Des 2014; 20: 1726-1750.
  5. Oliveira AM. DNA methylation: a permissive mark in memory formation and maintenance. Learn Mem 2016; 23: 587-593.
  6. Meier K, Recillastarga F. New insights on the role of DNA methylation from a global view. Front Biosci (Landmark Ed) 2017; 22: 644-668.
  7. Wang J, Gong L, Tan Y, Hui R, Wang Y. Hypertensive epigenetics: from DNA methylation to microRNAs. J Hum Hypertens 2015; 29: 575-82.
  8. Pouliot M C, Labrie Y, Diorio C, Durocher F. The Role of Methylation in Breast Cancer Susceptibility and Treatment. Anticancer Res 2015; 35: 4569-4574.
  9. Celebiler CA, Sevinc AI, Saydam S, Canda T, Baskan Z. Promoter methylation and expression changes of CDH1 and P16 genes in invasive breast cancer and adjacent normal breast tissue. Neoplasma 2010; 57: 465.
  10. De Leon MC, Cardenas H, Emerson R, Matei D. Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with cisplatin resistance in ovarian cancer. Gynecol Oncol 2015; 137: 173.
  11. Schmid G, Notaro S, Reimer D, Abdel-Azim S, Duggan-Peer M, Holly J, et al. Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer. BMC Cancer 2016; 16: 102.
  12. Zidan HE, Rezk NA, Alnemr AAA, Abdel Ghany AM. COX-2 gene promoter DNA methylation status in eutopic and ectopic endometrium of Egyptian women with endometriosis. J Reprod Immunol 2015; 112: 63-67.
  13. Andersson KL, Bussani C, Fambrini M, Polverino V, Taddei GL, Gemzell-Danielsson K, et al. DNA methylation of HOXA10 in eutopic and ectopic endometrium. Hum Reprod 2014; 29: 1906-1911.
  14. Sung CO, Lee KW, Han S, Kim SH. Twist1 is up-regulated in gastric cancer-associated fibroblasts with poor clinical outcomes. Am J Pathol 2011; 179: 1827-1838.
  15. Dirks RA, Stunnenberg HG, Marks H. Genome wide epigenomic profiling for biomarker discovery. Clin Epigenetics 2016; 8: 122.
  16. Li X, Bao X, Wang R. Neurogenesis-based epigenetic therapeutics for Alzheimer's disease. Mol Med Rep 2016; 14: 1043-1054.
  17. Stalberg P, Westin G, Thirlwell C. Genetics and epigenetics in small intestinal neuroendocrine tumours. J Intern Med 2016; 280: 584-594.
  18. Goel A. DNA methylation-based fecal biomarkers for the noninvasive screening of GI cancers. Future Oncol 2010; 6: 333-336.
  19. Guillamot M, Cimmino L, Aifantis I. The Impact of DNA Methylation in Hematopoietic Malignancies. Trends Cancer 2016; 2: 70-83.
  20. Geens M, Seriola A, Barbe L, Santalo J, Veiga A, Dée K, et al. Female human pluripotent stem cells rapidly lose X chromosome inactivation marks and progress to a skewed methylation pattern during culture. Mol Hum Reprod 2016; 2: 285-298.
  21. Hoeijmakers L, Kempe H, Verschure PJ. Epigenetic imprinting during assisted reproductive technologies: The effect of temporal and cumulative fluctuations in methionine cycling on the DNA methylation state. Mol Reprod Dev 2016; 83: 94-107
  22. Marks DL, Olson RL, Fernandez-Zapico ME. Epigenetic control of the tumor microenvironment. Epigenomics 2016; 8: 1671-1687.
  23. Larrent L, Wong E, Li G, Huynh T, Tsirigos A, Ong CT, et al. Dynamic changes in the human methylome during differentiation. Genome Res 2010; 20: 320-331.
  24. Grigorenko EL, Kornilov SA, Naumova OY. Epigenetic regulation of cognition: A circumscribed review of the field. Dev Psychopathol 2016; 28: 1285-1304.
  25. Wu H, Zhao M, Tan L, Lu Q. The key culprit in the pathogenesis of systemic lupus erythematosus: Aberrant DNA methylation. Autoimmun Rev 2016; 15: 684-689.
  26. Dowson C, O'Reilly S. DNA methylation in fibrosis. Eur J Cell Biol 2016; 95: 323-330.
  27. Xu P, Hu G, Luo C, Liang Z. DNA methyltransferase inhibitors: an updated patent review (2012-2015). Expert Opin Ther Pat 2016; 26: 1017-1030.
  28. Antelo M, Balaguer F, Shia J, Shen Y, Hur K, Moreira L, et al. A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer. PLos One 2012; 7: 45357.
  29. Earp MA, Cunningham JM. DNA methylation changes in epithelial ovarian cancer histotypes. Genomics 2015; 106: 311-321.
  30. Lee KW, Yeo SY, Sung CO, Kim SH. Twist1 is a key regulator of cancer-associated fibroblasts. Cancer Res 2015; 75: 73-85.
  31. Fantony JJ, Abern MR, Gopalakrishna A, Owusu R, Jack TayK, Lance RS, et al. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test forbladder cancer. Urol Oncol 2015; 33: 387.
  32. Satoh K, Hamada S, Kimura K, Kanno A, Hirota M, Umino J, et al. Up-regulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells. Am J Pathol 2008; 172: 926-939.
  33. Zou H, Feng X, Cao JG. Twist in hepatocellular carcinoma: pathophysiology and therapeutics. Hepatol Int 2015; 9: 399-405.
  34. Liu ZJ, Maekawa M. Polymerasechain reaction-based methods of DNA methylation analysis. Anal Biochem 2003; 317: 259-265.
Read More
Author biographies is not available.
Crossref
Scopus
Google Scholar
Europe PMC
Download this PDF file
PDF
Statistic
Read Counter : 810 Download : 439